John M. Fevig

947 total citations
21 papers, 641 citations indexed

About

John M. Fevig is a scholar working on Hematology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, John M. Fevig has authored 21 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 11 papers in Organic Chemistry and 6 papers in Molecular Biology. Recurrent topics in John M. Fevig's work include Blood Coagulation and Thrombosis Mechanisms (12 papers), Peptidase Inhibition and Analysis (5 papers) and Chemical Synthesis and Analysis (4 papers). John M. Fevig is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (12 papers), Peptidase Inhibition and Analysis (5 papers) and Chemical Synthesis and Analysis (4 papers). John M. Fevig collaborates with scholars based in United States and Germany. John M. Fevig's co-authors include Robert M. Knabb, Ruth R. Wexler, Larry E. Overman, Robert W. Marquis, Pancras C. Wong, Joseph Cacciola, Patrick Y. S. Lam, Richard Alexander, Joseph M. Luettgen and Karen A. Rossi and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Tetrahedron.

In The Last Decade

John M. Fevig

21 papers receiving 601 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
John M. Fevig 381 173 165 100 71 21 641
Michael J. Orwat 288 0.8× 181 1.0× 226 1.4× 271 2.7× 45 0.6× 16 782
Satoshi Komoriya 229 0.6× 149 0.9× 187 1.1× 125 1.3× 24 0.3× 19 523
Noriyasu Haginoya 184 0.5× 248 1.4× 116 0.7× 93 0.9× 43 0.6× 23 534
Valeria Chu 100 0.3× 123 0.7× 177 1.1× 163 1.6× 68 1.0× 31 544
Jan-Erik Nyström 214 0.6× 129 0.7× 108 0.7× 155 1.6× 50 0.7× 17 552
Bobby J. Lucas 274 0.7× 249 1.4× 164 1.0× 56 0.6× 84 1.2× 21 529
Kevin J. Filipski 185 0.5× 219 1.3× 54 0.3× 27 0.3× 42 0.6× 24 525
Shuaige Wang 171 0.4× 80 0.5× 103 0.6× 60 0.6× 16 0.2× 9 330
David D. Davey 170 0.4× 154 0.9× 76 0.5× 49 0.5× 18 0.3× 17 381
James R. Corte 227 0.6× 102 0.6× 64 0.4× 22 0.2× 39 0.5× 20 383

Countries citing papers authored by John M. Fevig

Since Specialization
Citations

This map shows the geographic impact of John M. Fevig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Fevig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Fevig more than expected).

Fields of papers citing papers by John M. Fevig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Fevig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Fevig. The network helps show where John M. Fevig may publish in the future.

Co-authorship network of co-authors of John M. Fevig

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Fevig. A scholar is included among the top collaborators of John M. Fevig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Fevig. John M. Fevig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fevig, John M., Karen A. Rossi, Keith J. Miller, et al.. (2012). Synthesis and SAR of 2,3,3a,4-tetrahydro-1H-pyrrolo[3,4-c]isoquinolin-5(9bH)-ones as 5-HT2C receptor agonists. Bioorganic & Medicinal Chemistry Letters. 23(1). 330–335. 10 indexed citations
2.
Li, Yunlong, John M. Fevig, Joseph Cacciola, et al.. (2006). Preparation of 1-(3-aminobenzo[d]isoxazol-5-yl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective, and efficacious inhibitors of coagulation factor Xa. Bioorganic & Medicinal Chemistry Letters. 16(19). 5176–5182. 24 indexed citations
3.
Fevig, John M., Joseph Cacciola, Karen A. Rossi, et al.. (2006). Preparation of 1-(4-methoxyphenyl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective and bioavailable inhibitors of coagulation factor Xa. Bioorganic & Medicinal Chemistry Letters. 16(14). 3755–3760. 43 indexed citations
4.
Quan, Mimi L., Qi Han, John M. Fevig, et al.. (2006). Aminobenzisoxazoles with biaryl P4 moieties as potent, selective, and orally bioavailable factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(7). 1795–1798. 16 indexed citations
5.
Lam, Patrick Y. S., Charles G. Clark, Renhua Li, et al.. (2003). Structure-Based Design of Novel Guanidine/Benzamidine Mimics:  Potent and Orally Bioavailable Factor Xa Inhibitors as Novel Anticoagulants. Journal of Medicinal Chemistry. 46(21). 4405–4418. 70 indexed citations
6.
Fevig, John M., Donald Pinto, Qi Han, et al.. (2001). Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core. Bioorganic & Medicinal Chemistry Letters. 11(5). 641–645. 31 indexed citations
7.
8.
Cacciola, Joseph, John M. Fevig, Pieter F. W. Stouten, et al.. (2000). Synthesis and activity studies of conformationally restricted α-ketoamide factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(11). 1253–1256. 11 indexed citations
9.
Fevig, John M., Pieter F. W. Stouten, Robert M. Knabb, et al.. (1999). Preparation of pyrrolidine and isoxazolidine benzamidines as potent inhibitors of coagulation factor Xa. Bioorganic & Medicinal Chemistry Letters. 9(8). 1195–1200. 11 indexed citations
10.
Fevig, John M., Joseph Cacciola, Richard Alexander, et al.. (1998). Rational design of boropeptide thrombin inhibitors: β,β-dialkyl-phenethylglycine P2 analogs of DuP 714 with greater selectivity over complement factor I and an improved safety profile. Bioorganic & Medicinal Chemistry Letters. 8(3). 301–306. 32 indexed citations
11.
Fevig, John M., Joseph Cacciola, Richard Alexander, et al.. (1998). Preparation of meta-amidino-N,N-disubstituted anilines as potent inhibitors of coagulation factor Xa. Bioorganic & Medicinal Chemistry Letters. 8(22). 3143–3148. 5 indexed citations
12.
Strickland, Corey L., et al.. (1998). Biochemical and Crystallographic Characterization of Homologous Non-peptidic Thrombin Inhibitors Having Alternate Binding Modes. Acta Crystallographica Section D Biological Crystallography. 54(6). 1207–1215. 1 indexed citations
13.
Cacciola, Joseph, Richard Alexander, John M. Fevig, & Pieter F. W. Stouten. (1997). The synthesis of lysine α-ketoamide thrombin inhibitord via an epoxy amide ring opening. Tetrahedron Letters. 38(33). 5741–5744. 5 indexed citations
14.
Fevig, John M., Matthew M. Abelman, David R. Brittelli, et al.. (1996). Design and synthesis of ring-constrained boropeptide thrombin inhibitors. Bioorganic & Medicinal Chemistry Letters. 6(3). 295–300. 30 indexed citations
15.
Cacciola, Joseph, John M. Fevig, Richard Alexander, et al.. (1996). Synthesis of conformationally-restricted boropeptide thrombin inhibitors. Bioorganic & Medicinal Chemistry Letters. 6(3). 301–306. 17 indexed citations
16.
Wityak, John, John M. Fevig, Sharon Jackson, et al.. (1995). Synthesis and antiplatelet activity of DMP 757 analogs. Bioorganic & Medicinal Chemistry Letters. 5(18). 2097–2100. 11 indexed citations
17.
Angle, Steven R., John M. Fevig, Steven D. Knight, Robert W. Marquis, & Larry E. Overman. (1993). Synthesis applications of cationic aza-Cope rearrangements. 24. The aza-Cope-Mannich approach to Strychnos alkaloids. Short stereocontrolled total syntheses of (.+-.)-dehydrotubifoline and (.+-.)-akuammicine. Journal of the American Chemical Society. 115(10). 3966–3976. 62 indexed citations
18.
Fevig, John M., Robert W. Marquis, & Larry E. Overman. (1991). New approach to Strychnos alkaloids. Stereocontrolled total synthesis of (.+-.)-dehydrotubifoline. Journal of the American Chemical Society. 113(13). 5085–5086. 54 indexed citations
19.
Burke, Steven D., David M. Armistead, Frank J. Schoenen, & John M. Fevig. (1986). An enolate claisen route to c-pyranosides. Tetrahedron. 42(11). 2787–2801. 42 indexed citations
20.
Burke, Steven D., David M. Armistead, & John M. Fevig. (1985). Ionophore synthesis. An enantioselective route to the left-wing of indanomycin (X- 14547A).. Tetrahedron Letters. 26(9). 1163–1166. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael J. Orwat Breakdown of academic impact, for papers by Satoshi Komoriya Breakdown of academic impact, for papers by Noriyasu Haginoya Breakdown of academic impact, for papers by Valeria Chu Breakdown of academic impact, for papers by Jan-Erik Nyström Breakdown of academic impact, for papers by Bobby J. Lucas Breakdown of academic impact, for papers by Kevin J. Filipski Breakdown of academic impact, for papers by Shuaige Wang Breakdown of academic impact, for papers by David D. Davey Breakdown of academic impact, for papers by James R. Corte
Rankless by CCL
2026